8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

June 23, 2005

Date of Report

(Date of earliest event reported)

RITA Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

000-30959	94-3199149
(Commission File Number)	(I.R.S. Employer Identification No.)

967 N. Shoreline Blvd.

Mountain View, CA 94043

(Address of principal executive offices, with zip code)

(510) 771-0400

(Registrant's telephone number, including area code)

Item 8.01. Other Events

On June 23, 2005, RITA Medical Systems, Inc., a Delaware corporation (“RITA”), announced the completion of the planned transfer of all its manufacturing operations to its Manchester, Georgia facility. A copy of RITA’s press release announcing publication of the article is attached as Exhibit 99.1 hereto and incorporated by reference herein.

Item 9.01.Financial Statements and Exhibits

(c) Exhibits:

99.1 Press Release of RITA Medical Systems, Inc. dated June 23, 2005

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RITA Medical Systems, Inc.
Date: June 23, 2005	By:	/s/ Donald Stewart
		Donald Stewart, Chief Financial Officer and
		Vice President Finance and Administration

RITA MEDICAL SYSTEMS, INC.

INDEX TO EXHIBITS

Exhibit Number	Description
99.1	Press Release of RITA Medical Systems, Inc. dated June 23, 2005.

EX-99.1

Contact:     EVC GroupRITA Medical Systems, Inc.

Investors: Stephen Pedroff, VP Marketing Communications

Doug Sherk/Jennifer Beugelmans510-771-0400

dsherk@evcgroup.comspedroff@ritamed.com

415-896-6820

Media:

Steve DiMattia

sdimattia@evcgroup.com

646-277-8706

RITA MEDICAL SYSTEMS COMPLETES MANUFACTURING TRANSFER TO GEORGIA FACILITY

Mountain View Manufacturing Facility Closure Is Expected to Result in More Than $1.0 million in Annualized Cost Savings

Completion of Manufacturing Transfer Signals End of Horizon Medical Products Merger Integration Activity

Fremont, Calif., June 23, 2005 -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced the completion of the planned transfer of all manufacturing activities to the Company’s Manchester, Georgia facility. The permanent closure of the Company’s Mountain View, California manufacturing facility is expected to result in annualized savings of more than $1.0 million. The Company noted that the Manchester, Georgia facility is currently producing all of the anticipated 2005 product demand for both the specialty access catheter and the radiofrequency ablation product lines.

The consolidation of all manufacturing to the Company’s Manchester, Georgia facility was a key component of the projected cost savings associated with the merger with Horizon Medical Products, which was completed in July of 2004.

Joseph DeVivo, President and CEO of RITA Medical commented, “While we expect to generate additional operating efficiencies during the remainder of this year and into 2006, closing the Mountain View facility signals an end to our integration activities following the merger last year. The savings associated with the consolidation of the facilities was an important element of the merger rationale and we believe this achievement is a significant milestone indicative of our ability to execute on our long-term strategy of achieving profitable growth. With the Georgia facility’s current production we anticipate that we can meet the growing worldwide demand for our products. We also expect that the lower manufacturing costs associated with the completion of the transition and the increased efficiencies of manufacturing all of our products in one facility, will result in an improvement in gross margins, beginning in the third quarter.”

MORE - MORE - MORE

RITA MEDICAL COMPLETES MANUFACTURING TRANSFER TO GEORGIA

2-2-2

About RITA Medical Systems, Inc.

RITA Medical Systems develops, manufactures and markets innovative products for cancer patients including radiofrequency ablation (RFA) systems for treating cancerous tumors as well as percutaneous vascular and spinal access systems. The Company's oncology product lines include implantable ports, some of which feature its proprietary Vortex® technology; tunneled central venous catheters; safety infusion sets and peripherally inserted central catheters used primarily in cancer treatment protocols. The proprietary RITA system uses radiofrequency energy to heat tissue to a high enough temperature to ablate it or cause cell death. In March 2000, RITA became the first RFA Company to receive specific FDA clearance for unresectable liver lesions in addition to its previous general FDA clearance for the ablation of soft tissue. In October 2002, RITA again became the first company to receive specific FDA clearance, this time, for the palliation of pain associated with metastatic lesions involving bone. The RITA Medical Systems website is at www.ritamedical.com.

The statements in this news release related to the company’s future financial operating performance, including without limitation the Company’s manufacturing capabilities, the costs and success of the Company’s integration with Horizon, the Company’s ability to achieve and sustain profitability and the growth in demand for its products, are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Information regarding these risks is included in the Company's filings with the Securities and Exchange Commission.

# # # #